Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4005362 | American Journal of Ophthalmology | 2008 | 17 Pages |
Abstract
Lesion location and drug use that affects virus activity may influence the severity of lesion border opacity, a measure that may be more useful than lesion type in future clinical studies of CMV retinitis. In contrast to earlier concepts, CMV retinitis does not seem to be a fovea-sparing disease. Findings in this study can serve as a reference for investigations into possible changes in CMV retinitis since the introduction of HAART.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Gary N. Holland, Jean D. Vaudaux, Samuel M. Jeng, Fei Yu, David T. Goldenberg, Ina-Caren Folz, William G. Cumberland, Colin A. McCannel, Craig J. Helm, W. David Hardy, UCLA CMV Retinitis Study Group UCLA CMV Retinitis Study Group,